Why Catalogue Photography Is Not Identity Evidence
Catalogue photography serves a clear commercial purpose: it presents a product’s general appearance, packaging style and presentation to prospective buyers. It is not, and never should be, treated as a record of identity for a specific batch. When an in-vitro control run fails, laboratory teams often retrace their steps with heightened scrutiny. At that point, it can be tempting to compare the vial received at goods-in with the image shown on a supplier’s website. That comparison may confirm that the correct product line was ordered, but it cannot confirm that the material inside the vial matches the analytical specification for the batch in hand. Visual cues such as vial size, label layout, cap colour or box design are subject to change and are explicitly not indicators of identity, analytical quality or manufacturing origin.
Identity evidence at goods-in must come from documentation tied to the batch: the Certificate of Analysis (CoA), the vial label reference, and any associated Internal Test Reference (ITR). For example, Research Sciences uses a label reference format that combines the SKU code and expiry date, such as BPC10-03/27, which links to the corresponding CoA. That reference—not a photograph—is the starting point for verifying what was supplied. When an in-vitro control run has failed, the first question should be whether the material’s identity and purity are supported by the batch CoA, not whether the vial looks like the catalogue image. Researchers should open and check the CoA that accompanies the specific batch, and should reconfirm any published purity or testing figures against the live site and the batch document. For laboratories that source materials from Peptides uk, the published documentation framework—batch-level CoAs and labelled references—provides a starting point, but the responsibility remains with the receiving lab to verify each delivery against its own records.
It is also important to remember that all materials are supplied strictly for controlled laboratory and analytical research. They are not for human or veterinary use, and must never be treated as medicines, medical devices, injectables, treatments or food supplements. Catalogue photography is a marketing tool; identity evidence is a regulatory and scientific necessity. Keeping those two categories separate is essential for any laboratory that needs to investigate a failed control run without introducing avoidable confusion.
Goods-In Workflow After a Failed In-Vitro Control Run
When a control run fails, the goods-in process should shift from routine receipt to a documented verification workflow. The aim is to establish whether the materials received are what the documentation says they are, and whether any discrepancy could have contributed to the failed run. The first step is to quarantine the received materials—do not open, reconstitute or use them until the documentation has been reviewed. Catalogue images should be set aside entirely during this phase. Instead, check the vial label reference against the packing slip and the batch CoA. Confirm that the SKU and expiry date match the order, and that the CoA is the one associated with that specific batch. If the product was restocked, the ITR may be the same as earlier stock, but an ITR does not confirm that separate deliveries come from the same production lot or have had separate independent testing. That distinction matters when investigating a failed run.
Next, document the condition of the goods on arrival: packaging integrity, temperature indicators if present, and any visible damage. Record the batch reference, ITR (if shown), and the CoA version. If the control run failed, compare the handling and storage records of the material used in that run with the supplier’s published guidance—for example, storage of lyophilised peptides at –20°C or below, protected from moisture, heat and light, and avoidance of repeated freeze–thaw cycles. None of these checks rely on catalogue photography. They rely on written evidence. It is also prudent to review whether the failed run could have been caused by assay design, diluent volume, concentration calculations or equipment calibration. Separating material identity from procedural error is part of a robust investigation.
Throughout this workflow, remember that the materials are not for human or veterinary use and must be handled only within an in-vitro laboratory context. If a discrepancy is found between the label, the CoA and the order, contact the supplier with the label reference and batch details. Do not use a catalogue image as proof of identity in any correspondence or internal report. The evidence trail should consist of documents, not pictures.
Building a Reliable Identity Evidence Trail for Future Research
After a failed control run, the laboratory should strengthen its identity evidence trail so that future goods-in checks are faster and more reliable. This means training receiving staff to prioritise documentation over visual familiarity. A vial that looks different from a catalogue photograph may still be the correct material; a vial that looks identical may belong to a different batch with different analytical results. Cap colour and packaging may vary between deliveries, and these variations are not indicators of identity, quality or manufacturing origin. The only reliable identity evidence is the batch-specific CoA, the label reference and the ITR where applicable.
Consider maintaining a goods-in log that records the supplier, product name, SKU, label reference, expiry date, ITR, CoA version and the date of receipt (using month-and-year format where a full date is not required). When an in-vitro control run fails, this log allows the team to trace exactly which batch was used, which CoA applied, and whether the material had been stored correctly before use. If the supplier publishes claims such as “≥99% Verified Purity” or “CoAs Janoshik Analytical Reports”, those should be treated as the shop’s current published wording and reconfirmed on the live site and on the batch CoA. No single figure should be assumed to apply across all batches or all products.
Finally, keep the separation between catalogue photography and identity evidence explicit in standard operating procedures. Catalogue images may be used for ordering or inventory labelling, but they must never be cited as evidence of identity in an investigation. Identity evidence is documentary, batch-specific and verifiable. All materials remain not for human or veterinary use, and any reconstitution or handling must stay within a controlled in-vitro laboratory workflow. By treating goods-in as an evidence-gathering step rather than a visual matching exercise, laboratories can respond to a failed control run with clarity and traceability.
